And not the semiconductor kind of chips either: Boston-based biotech firm Emulate
raised US-$82 million to develop their "organ-on-a-chip" technology.
Their what? It usually takes anywhere from 10-15 years to bring a drug from the lab to the market. That process is often so long because scientists must test drugs on animal models and cells. However, those models aren’t exact replicas of human cells, and therefore results from pre-clinical trials often don’t produce the same results in humans.
- When that happens, scientists have to start from scratch and return back to the drawing board.
This is where organ-on-a-chip technology comes in: the USB stick-sized chips are filled with human cells from certain organs, like the lung or liver, and replace the use of traditional animal models and cells.
- Because the chips are lined with human cells, it’s more like testing the drug on humans themselves.
Emulate, which was founded in 2013, will use the funds to work with pharmaceutical companies to develop tailor-made chips.
Zoom out: Organ-on-a-chip tech will speed up the time it takes and reduce the costs involved to develop a drug.